BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16928329)

  • 1. [Animal trials for mPEG-modified red blood cells].
    Qiu Y; Tan YX; Li LL; Li SB; Lü QS; Zha Y; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):816-21. PubMed ID: 16928329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of normal and methoxypolyethylene glycol-modified murine red cells on swimming endurance and hippocampal injury in hypoxic mice.
    Tan Y; Ji S; Li S; Wang J; Jin X; Zhang Y
    Transfusion; 2008 Sep; 48(9):1954-8. PubMed ID: 18522709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary study on xenotransfusion from porcine red blood cell into Rhesus monkey].
    Tan YX; Ji SP; Lu YP; Zhang CL; Li LL; Gong F; Zhang JG; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):150-5. PubMed ID: 16584613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: size does matter.
    Bradley AJ; Murad KL; Regan KL; Scott MD
    Biochim Biophys Acta; 2002 Apr; 1561(2):147-58. PubMed ID: 11997115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rh antigen stability of mPEG modified red blood cells].
    Qiu Y; Zha Y; Tan YX; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Oct; 14(5):1020-3. PubMed ID: 17096911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol).
    Murad KL; Mahany KL; Brugnara C; Kuypers FA; Eaton JW; Scott MD
    Blood; 1999 Mar; 93(6):2121-7. PubMed ID: 10068687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation and purification of methoxypoly(ethylene glycol) grafted red blood cells via two-phase partitioning.
    Bradley AJ; Scott MD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 807(1):163-8. PubMed ID: 15177175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of murine mPEG-red blood cells and the risk of anti-PEG antibodies in human blood donors.
    Le Y; Toyofuku WM; Scott MD
    Exp Hematol; 2017 Mar; 47():36-47.e2. PubMed ID: 27864153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transfusion survival of biotin-labeled allogeneic RBCs in adult horses.
    Mudge MC; Walker NJ; Borjesson DL; Librach F; Johns JL; Owens SD
    Vet Clin Pathol; 2012 Mar; 41(1):56-62. PubMed ID: 22251607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous Infant and Allogeneic Adult Red Cells Demonstrate Similar Concurrent Post-Transfusion Survival in Very Low Birth Weight Neonates.
    Widness JA; Kuruvilla DJ; Mock DM; Matthews NI; Nalbant D; Cress GA; Schmidt RL; Strauss RG; Zimmerman MB; Veng-Pedersen P
    J Pediatr; 2015 Nov; 167(5):1001-6. PubMed ID: 26363547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell transfusion during septic shock in the ICU.
    Perner A; Smith SH; Carlsen S; Holst LB
    Acta Anaesthesiol Scand; 2012 Jul; 56(6):718-23. PubMed ID: 22385470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice.
    Osei-Hwedieh DO; Kanias T; Croix CS; Jessup M; Xiong Z; Sinchar D; Franks J; Xu Q; M Novelli E; Sertorio JT; Potoka K; Binder RJ; Basu S; Belanger AM; Kim-Shapiro DB; Triulzi D; Lee JS; Gladwin MT
    EBioMedicine; 2016 Sep; 11():239-248. PubMed ID: 27523807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery.
    McKenny M; Ryan T; Tate H; Graham B; Young VK; Dowd N
    Br J Anaesth; 2011 May; 106(5):643-9. PubMed ID: 21414977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.
    Hendrickson JE; Desmarets M; Deshpande SS; Chadwick TE; Hillyer CD; Roback JD; Zimring JC
    Transfusion; 2006 Sep; 46(9):1526-36. PubMed ID: 16965580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-mediated immunocamouflage of red blood cells: effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells.
    Wang D; Kyluik DL; Murad KL; Toyofuku WM; Scott MD
    Sci China Life Sci; 2011 Jul; 54(7):589-98. PubMed ID: 21701803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-D in D- recipients transfused with D+ red blood cells.
    Yazer MH; Triulzi DJ
    Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs.
    Garratty G
    Transfus Med Rev; 2004 Oct; 18(4):245-56. PubMed ID: 15497125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical camouflage of antigenic determinants: stealth erythrocytes.
    Scott MD; Murad KL; Koumpouras F; Talbot M; Eaton JW
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7566-71. PubMed ID: 9207132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age of transfused red cells and early outcomes after cardiac surgery.
    Yap CH; Lau L; Krishnaswamy M; Gaskell M; Yii M
    Ann Thorac Surg; 2008 Aug; 86(2):554-9. PubMed ID: 18640333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical calculation of lifespan of transfused RBCs in sickle cell disease patients.
    Kim J; Usmani A; De Simone N; Sarode R
    Transfus Apher Sci; 2018 Feb; 57(1):46-49. PubMed ID: 29196100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.